Valtecne SpA

Valtecne SpA EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Valtecne SpA (VLT.MI) as of Oct 30, 2026 is 31.52. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 10.30 — a change of 206.06% (higher).

EV/FCF

31.52

YoY

206.06%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Valtecne SpA is 2025 31.52 . EV/FCF (Enterprise Value to Free Cash Flow) of Valtecne SpA was 2024 10.30 . It decreases by 206.06% higher compared to the previous year.

The Valtecne SpA EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
23.44 EUR
Jan 1, 2020
-166.22 EUR
Jan 1, 2021
-12.05 EUR
Jan 1, 2022
-76.93 EUR
Jan 1, 2023
22.05 EUR
Jan 1, 2024
10.30 EUR
Jan 1, 2025
31.52 EUR
The Valtecne SpA EV/FCF history
YEAREV/FCFYoY
31.52+206.06%
10.30-53.29%
22.05-128.66%
-76.93+538.32%
-12.05-92.75%
-166.22-809.20%
23.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valtecne SpA Stock analysis

What does Valtecne SpA do? Valtecne SpA produces precision-machined mechanical components for orthopedic and veterinary surgery, including cutting guides, pin pliers, femoral sizers, and tibial resection guides. The company also manufactures implantable devices such as femoral stems, femoral heads, stem collars, and tibial implants. These products are sold globally to medical device manufacturers and healthcare providers specializing in orthopedic and veterinary care. Valtecne SpA generates revenue through the sale of these high-precision surgical instruments and implantable devices to international medical markets. The company operates in the precision-machined sector, focusing on specialized instruments for orthopedic and veterinary surgery. Its product range includes both surgical tools like cutting guides and implantable components such as femoral stems. Valtecne SpA's global operations ensure its products reach medical device companies and clinics worldwide, supporting the production of advanced surgical solutions. Valtecne SpA's revenue model is based on manufacturing and selling precision-machined components for medical applications. The company's key products are surgical instruments and implantable devices used in orthopedic and veterinary procedures. By targeting medical device manufacturers and healthcare providers, Valtecne SpA secures contracts for its high-precision components, which are essential for surgical procedures and patient care. Valtecne SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valtecne SpA stock

EV/FCF (Enterprise Value to Free Cash Flow) of Valtecne SpA is 31.52 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Valtecne SpA changed from 10.30 to 31.52, representing a 206.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Valtecne SpA since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Valtecne SpA with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valtecne SpA

All Key Metrics — Valtecne SpA